In vivo release of [3H]‐purines by quinolinic acid and related compounds

30Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In vivo release of [3H]‐purines from the cortex of anaesthetized rats was measured and the actions of excitatory amino acids and analogues investigated. High KCl, N‐methyl‐dl‐aspartate (NMDLA) and quinolinic acid produced a large increase in basal release of labelled materials. Glutamate, quisqualate and kainate had less effect. The N‐methyl‐d‐aspartic acid (NMDA)‐preferring receptor antagonist, 2‐amino‐7‐phosphono‐heptanoic acid, significantly reduced the release evoked by NMDLA and quinolinate but not that produced by the other agonists. Kynurenic acid, a compound metabolically related to quinolinic acid, reduced the release due to NMDLA and quinolinate but not glutamate. The results add further support to the suggestion that quinolinic acid acts on the NMDA‐preferring receptor. 1983 British Pharmacological Society

Cite

CITATION STYLE

APA

Perkins, M. N., & Stone, T. W. (1983). In vivo release of [3H]‐purines by quinolinic acid and related compounds. British Journal of Pharmacology, 80(2), 263–267. https://doi.org/10.1111/j.1476-5381.1983.tb10029.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free